In the last several years, targeted therapies have shown great promise in the treatment of malignant pleural mesothelioma, but the rare, asbestos-related form of cancer continues to claim lives. In an attempt to find a more effective method of delivering these state-of-the-art drugs, researchers from the Hyogo College of Medicine have developed a minimally invasive,
Dr. Sunil Singhal is a thoracic surgeon at the University of Pennsylvania Perelman Center for Advanced Medicine and the Penn Presbyterian Medical Center. He specializes in the surgical treatment of illnesses of the lungs and chest cavity, including pleural mesothelioma. Dr. Singhal also directs thoracic surgery research. Education and Training Dr. Singhal earned a degree
There are few options available to those diagnosed with malignant mesothelioma. Though patients eligible for surgery may choose a less aggressive approach that promises shorter recovery time, surgeons often find mid-procedure that a more invasive procedure is required. A recent study revealed how patients fare when their surgery shifts mid-stream.
Though individuals with a known history of exposure to asbestos are at high risk for malignant mesothelioma, symptoms do not necessarily mean that they have the rare form of cancer. Accurate diagnosis is essential to getting the right treatment but can be time consuming and invasive. A new study conducted by researchers in the United
Back when COVID-19 first made itself known in the United States, experts in mesothelioma and other cancers worried that the pandemic would have long-term impacts on diagnosis, treatment and research. Eighteen months later the virus is still with us, but so are vaccines and boosters. In a recent interview, Ned Sharpless, director of the National
A year after the introduction of vaccinations against COVID-19, patients with cancers like malignant mesothelioma are being warned of the dangers of breakthrough infections. A report published in the Annals of Oncology confirms that these medically fragile patients are extremely susceptible to severe outcomes. Researchers Cite Vulnerabilities of Those with Mesothelioma Since the beginning of the global pandemic,
Malignant mesothelioma is among the most challenging cancers to treat. The rare form of cancer, caused by exposure to asbestos, has proven resistant to chemotherapy, and as each new therapeutic has been introduced its tumors have revealed a new defense. In response to the use of checkpoint inhibitors and CAR-T protocols, mesothelioma cells secrete transforming
People diagnosed with malignant pleural mesothelioma have limited options for treatment. When deciding whether to pursue surgery they need as much information as possible about their own condition and how far the cancerous cells have spread within their bodies. A recent study from researchers at the University of Pennsylvania has revealed that one of the
One of the most important things that happen after a patient is diagnosed with malignant mesothelioma — or any form of cancer — is a process known as staging. Doctors need to know how far the cancer has spread in order to determine the best treatment protocol, and do so through diagnostic testing. In most
Days before the 20th anniversary of the 9/11 attacks, an Australian research team reported a significant increase in leukemia diagnoses, as well as an increase in asbestos-related lung conditions like malignant mesothelioma, in general responders and firefighters enrolled in the World Trade Center Health Program. The study confirmed fears about asbestos contamination at the site and